Caterpillar (CAT) Offering Possible 66.67% Return Over the Next 27 Calendar Days

Caterpillar's most recent trend suggests a bearish bias. One trading opportunity on Caterpillar is a Bear Call Spread using a strike $124.00 short call and a strike $129.00 long call offers a potential 66.67% return on risk over the next 27 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $124.00 by expiration. The full premium credit of $2.00 would be kept by the premium seller. The risk of $3.00 would be incurred if the stock rose above the $129.00 long call strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for Caterpillar is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving down which suggests that the medium-term momentum for Caterpillar is bearish.

The RSI indicator is below 20 which suggests that the stock is in oversold territory.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Caterpillar

Why British Steel is hoping to avoid scrapheap
Thu, 23 May 2019 03:00:26 +0000
During a ceremony to celebrate the resurrection of British Steel almost three years ago, a flag bearing its new logo was proudly raised at the entrance to the Scunthorpe steelworks. The company entered insolvency on Wednesday after talks failed between its lenders, private equity owner Greybull Capital and the government over a £30m state bailout — only weeks after ministers handed it a £120m emergency loan.

This Dow Stock Is Still Undervalued
Wed, 22 May 2019 22:12:59 +0000
Investors looking to own shares of blue-chip companies often turn to the Dow Jones Industrial Average, a popular gauge of the broader stock market. All of these companies also pay a dividend, such as Caterpillar Inc. (CAT), one of the most undervalued stocks in the Dow Jones Industrial Average. Caterpillar has been persistently undervalued throughout 2019.

Jim Cramer: Any US-China trade deal will send the market into an ‘epic rebound'
Tue, 21 May 2019 22:08:39 +0000
“Today's rally was a reminder that if we do get any breakthrough in the trade talks whatsoever, you're going to get an epic rebound” the “Mad Money” host said. As of Tuesday, an imminent deal seems unlikely, with both countries refusing to compromise, Cramer said. Tuesday's stock market action is an indicator of what could come if the United States and China strike a trade deal — even if it's a bad one, CNBC's Jim Cramer said.

Forecast: How The Dow Can Reach 28,762 In 18 Months
Tue, 21 May 2019 16:00:03 +0000
Investors in the Dow Jones Industrial Average ETF might wonder what's next for the widely-watched benchmark. Analysts think it's 28,762 in 18 months.

2 Stocks to be Wary Of (And One Defensive Play)
Tue, 21 May 2019 08:59:33 +0000
The trade war with China has reignited, and while the tech companies may be getting the headlines, export-oriented industrials have also felt immediate effects. China is an important market for heavy construction and agricultural equipment, and the imposition of protective tariffs has made a mark on the import-export trade.We’ll dive into TipRanks’ analyst database to look at two major industrial companies feeling the pain from China, as well as one strong defensive play to minimize the hurt on your portfolio. Caterpillar, Inc. (CAT – Research Report)Despite beating expectations in the China market earlier this year, Caterpillar now says it expects full-year China-sales results to come in flat at best. This is a serious setback, as Caterpillar makes 10% of its global sales to China. Combined with a drop in operating margin – reported at 18.5% last month, down from 19.7% one year ago – the company is facing a serious headwind in East Asia.Quoted in Canada’s Globe and Mail newspaper, five-star analyst Stephen Volkmann (Track Record & Ratings) noted both points, saying, “Caterpillar has most exposure to China in their construction industry business and that business was just a bit disappointing on revenue and margins.”Caterpillar stock has had a difficult time gaining traction in recent years, as its share price peaked in January 2018 and has been on an uneven downward slope since then. With the end of Q2 2019, the company moved to placate shareholders, by boosting the dividend 20% to $1.03 per share ($4.12 annualized), which increased the yield to a respectable 3.37%. Shares gained $4 in the next session but are down $17 since.While CAT is facing headwinds, the outlook is not entirely gloomy. Oppenheimer’s Noah Kaye (Track Record & Ratings) set a ‘Hold’ on the stock, but his comments acknowledge that the company has extensive resources: “We got much of what we were looking for from CAT’s Investor Day last week. The company provided an updated view on its structurally improved cross-cycle margin and cash flow metrics… We believe CAT’s O&E model has successfully enabled the company to deliver stronger cash generation peak-to-trough and supported its strong balance sheet, enabling a more shareholder-friendly approach to capital allocation.”Overall, CAT retains a ‘Moderate Buy’ from the analyst consensus, including 9 buy, 3 hold, and 2 sell reviews. Shares sell for $122 as of May 20, and the average price target of $150 suggests a 22% upside potential.View CAT Price Target & Analyst Rating Detail Deere & Co. (DE – Research Report)Nothing runs like a Deere, but investors ran away from Deere shares after the May 17 Q2 earnings report. The manufacturer of agricultural equipment (from backyard riding mowers to giant agribusiness harvester combines, plus everything in between) missed the EPS forecast by 2%, reporting $3.52 against the expected $3.61. Despite the earnings miss, net equipment sales revenues came in just above the $10.12 billion expectation, at $10.3 billion.According to the company, however, investors should not expect to keep seeing revenue beats this year. Deere lowered guidance on 2019 net income from $3.6 billion to $3.3 billion. Company CEO Sam Allen said of the lower guidance, “Although the long-term fundamentals for our businesses remain favorable, softening conditions in the agricultural sector have led Deere to adopt a more cautious financial outlook for the year. The lower forecast is partly a result of actions we are taking to prudently manage field inventories, which will cause production levels to be below retail sales in the second half of the year.”DE shares dropped 7.5% after the earnings report.Wall Street’s analysts have also seen the weakness in DE, even those setting ‘buy’ ratings on the stock. From RBC Capital, Seth Weber (Track Record & Ratings) says of the lowered income guidance, “…the revision is not surprising in light of the U.S.-China trade tensions and bad weather.” He lowered his price target by 10%, to $175.Stanley Elliot (Track Record & Ratings), of Stifel, also notes the softness in the agribusiness sector. He says the lowered income projection is driven by “a cocktail of negative developments in terms of trade, late plantings and swine flu.” His price target, $171, suggests a 26% upside for the stock.Deere holds a ‘Moderate Buy’ rating on the analyst consensus, based on 5 buy, 4 hold, and 1 sell rating given in the past three months. The $155 average price target that indicates a 14% upside potential from the current share price of $135.View DE Price Target & Analyst Rating Detail Johnson & Johnson (JNJ – Research Report)Consumer health care companies, emphasizing the everyday items that everyone needs no matter the state of the economy, are among the stocks usually seen as ‘recession proof.’ This doesn’t mean that they won’t drop when the market drops; rather, it means that they’ll experience less volatility. You can expect these defensive stocks to outperform when the major indexes fall or make slow gains, but they’ll also tend to lag a bit when the markets see a sharp rise.Johnson & Johnson is a classic case. JNJ released its Q1 earnings, missing the EPS by 2 cents, on April 16. Since then, the stock has slipped, risen, and slipped again, and is flat overall. On a longer-term view, JNJ is up 7.3% year-to-date and 11.4% over the past 12 months. The S&P 500, for April, is down over 2%, and in the last 12 months is only up 4%.Outperforming market slips is not JNJ’s only defensive attribute. The stock pays out a regular dividend, currently 95 cents per quarter for a 2.75% annual yield. The company has made a policy of steady, if modest, dividend increases, dating back to the early 1990s.The analysts, of course, have taken note of JNJ’s dependability in delivering profits and rewarding shareholders. Raymond James analyst Jayson Bedford (Track Record & Ratings), just after the earnings report, raised his price target to $147 (for a 6% upside), and said, “Growth was still much better than expected, which gives us more confidence in our estimates.”More recently, five-start analyst Joanne Wuensch (Track Record & Ratings) of BMO Capital, noted JNJ’s attraction in a down market. In her note on the stock, she said, “J&J's discipline to acquire and divest assets in its health care portfolio, its pristine balance sheet and its high dividend yield make the stock a strong defensive choice.” Her price target, $157, suggests an upside potential of 13%.JNJ maintains a ‘Moderate Buy’ analyst consensus rating, based on 6 buys and 5 holds given in the past three months. Shares sell for $138; the average price target of $148 indicates a modest upside potential of 7%.View JNJ Price Target & Analyst Rating Detail Enjoy Research Reports on the Stocks in this Article:Caterpillar, Inc. (CAT) Research ReportDeere & Co. (DE) Research ReportJohnson & Johnson (JNJ) Research Report

Be Sociable, Share!

Related Posts


MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.

This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.

The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The educational training program and software services are provided to improve financial understanding.

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.